Skip to main content
. 2011 Aug 18;6(8):e23758. doi: 10.1371/journal.pone.0023758

Table 1. Patient characteristics.

VLA-4 Low/CD38 Low VLA-4 High/CD38 High VLA-4 Low/CD38 High VLA-4 High/CD38 Low Total
Nā€Š=ā€Š 83 30 13 18 144
Characteristics Percent of patients (%)
Sex
Female 45 43 31 44 43
Male 55 57 69 56 57
Rai stage
0 47 23 46 22 39
I-II 48 53 46 56 50
III-IV 5 23 8 22 11
Treatment status
Chemonaive 70 40 54 39 58
Treated 30 60 46 61 42
Risk parameters
IgVH UMT 10 62 70 54 31
FISH High-risk 6 31 27 27 15
ZAP-70 High-risk 21 75 60 40 38

IgVH UMT, unmutated IgVH; FISH High-risk, either del17p, del11q or tri12;